During the past decade, Bravis ziekenhuis - Locatie Roosendaal conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bravis ziekenhuis - Locatie Roosendaal" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Milestone Pharmaceuticals Inc." with 1 trials sponsored, "NewAmsterdam Pharma" with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bravis ziekenhuis - Locatie Roosendaal" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Bravis ziekenhuis - Locatie Roosendaal" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Dyslipidemias" (1 trials), "Esophageal Cancer" (1 trials) and "Familial Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Bravis ziekenhuis - Locatie Roosendaal" in a lesser frequency.

Most popular intervention types in "Bravis ziekenhuis - Locatie Roosendaal" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-fluorouracil" (1 trials), "Apixaban" (1 trials), "Capecitabine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bravis ziekenhuis - Locatie Roosendaal" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Bravis ziekenhuis - Locatie Roosendaal". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bravis ziekenhuis - Locatie Roosendaal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bravis ziekenhuis - Locatie Roosendaal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".